Enanta’s portfolio of RSV replication inhibitors with potential for first-in-disease and best-in-disease treatment.

: Earlier today, Sheriff David Favro met with the family of Margo Diaz at the Clinton County Sheriff’s Office, according to a ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem cell company treating those who suffer in pain ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced a $1.5 million, three-year grant to Blue Circle Health, a nonprofit providing free, ...

His lack of literacy made him reluctant to follow doctor’s orders, went to Jones' home to figure out what caused these ...

Data from NHANES reveal a 43% increase in heart failure prevalence over 35 years, though age-standardized rates remained relatively stable.

Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that ...

Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that ...

Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...

The boy was just six years old when the horrifying abuse began but it was years before he confided in his mum and made a ...

Approximately one in three deaths in the U.S. is caused by cardiovascular disease, according to the U.S. Centers for Disease Control and Prevention. New research indicates that splitting the ...